For the quarter ending 2026-03-31, TEVA has $40,040M in assets. $31,809M in debts. $3,741M in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 3,741 | 3,556 | 2,203 | 2,161 |
| Accounts receivables, net of allowance for credit losses of 86million and 81million as of march31, 2026 and december31, 2025, respectively | 3,393 | 3,709 | 3,810 | 3,564 |
| Inventories | 3,176 | 3,179 | 3,323 | 3,497 |
| Prepaid expenses | 1,070 | 1,122 | 1,115 | 1,084 |
| Other current assets | 535 | 539 | 477 | 472 |
| Assets held for sale | 1,794 | 1,842 | 1,809 | 1,842 |
| Total current assets | 13,710 | 13,946 | 12,736 | 12,620 |
| Deferred income taxes | 2,190 | 2,191 | 1,634 | 1,781 |
| Othernon-currentassets | 377 | 405 | 444 | 470 |
| Property, plant and equipment, net | 3,998 | 4,080 | 4,820 | 4,810 |
| Operating lease right-of-use assets, net | 335 | 345 | 342 | 358 |
| Accumulated amortization | 0 | 0 | 0 | 0 |
| Gross carrying amount net of impairment | 16,966 | 17,111 | 17,139 | 17,207 |
| Accumulated amortization | 13,357 | 13,330 | 13,203 | 13,065 |
| Identifiable intangible assets, net | 3,609 | 3,781 | 3,936 | 4,142 |
| Goodwill | 15,822 | 16,000 | 15,945 | 15,949 |
| Total assets | 40,040 | 40,748 | 39,856 | 40,131 |
| Short-term debt | 2,612 | 1,820 | 24 | 464 |
| Sales reserves and allowances | 3,707 | 4,143 | 4,134 | 4,050 |
| Accounts payables | 2,596 | 2,531 | 2,355 | 2,498 |
| Employee-related obligations | 555 | 739 | 561 | 481 |
| Accrued expenses | 2,616 | 2,687 | 2,989 | 3,095 |
| Other current liabilities | 1,111 | 1,182 | 1,103 | 940 |
| Liabilities held for sale | 334 | 354 | 324 | 334 |
| Total current liabilities | 13,532 | 13,456 | 11,491 | 11,861 |
| Deferred income taxes | 273 | 296 | 399 | 440 |
| Other taxes and long-term liabilities | 3,709 | 3,808 | 3,664 | 3,938 |
| Senior notes and loans | 14,015 | 14,986 | 16,766 | 16,763 |
| Operating lease liabilities | 280 | 288 | 283 | 296 |
| Total long-term liabilities | 18,277 | 19,379 | 21,111 | 21,436 |
| Total liabilities | 31,809 | 32,834 | 32,602 | 33,297 |
| Redeemable non-controlling interests | - | - | 0 | 0 |
| Ordinary shares of nis 0.10 par value per share march31, 2026 and december31, 2025 authorized 2,495million shares issued 1,271million shares and 1,257million shares, respectively | 59 | 58 | 58 | 58 |
| Additionalpaid-incapital | 28,203 | 28,133 | 28,038 | 28,003 |
| Accumulated deficit | -13,394 | -13,762 | -14,243 | -14,676 |
| Accumulated other comprehensive loss | -2,512 | -2,391 | -2,475 | -2,431 |
| Treasury shares as of march31, 2026 and december31, 2025 107million ordinary shares | 4,128 | 4,128 | 4,128 | 4,128 |
| Stockholders' equity attributable to teva shareholders | 8,228 | 7,910 | 7,250 | 6,827 |
| Non-controlling interests | 4 | 4 | 4 | 7 |
| Total equity | 8,232 | 7,914 | 7,254 | 6,834 |
| Total liabilities and equity | 40,040 | 40,748 | 39,856 | 40,131 |
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)